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ABSTRACT
Background and Objectives: Hepatic artery chemoem-
bolization (HACE) used to treat neuroendocrine tumors met-
astatic to the liver has shown both survival benefit and
improvement in symptoms. The development of hepatic
necrosis after HACE is rare, but the consequences can be
devastating. We report the first case of laparoscopic manage-
ment of extensive hepatic necrosis occurring after HACE.
Case Report: A 58-year-old man with neuroendocrine
tumor metastatic to the liver underwent HACE in addition
to medical management. He had undergone previous bil-
iary stenting for biliary obstruction. After HACE was per-
formed via the right hepatic artery, the patient developed
sepsis due to right hepatic lobe infarction. Percutaneous
drainage and antibiotics were attempted for 2 months, but
hepatic debridement was ultimately required due to re-
peated drain malfunction and septic complications. Lapa-
roscopic necrosectomy was performed with ease and with
little blood loss. The patient quickly recovered without
any further infectious complications.
Conclusion: Infected hepatic necrosis resulting from
HACE that fails percutaneous management can be suc-
cessfully managed with laparoscopic necrosectomy. This
report adds to the growing evidence that minimally inva-
sive techniques can be used to manage complicated he-
patic conditions.
Key Words: Laparoscopic surgery, Hepatic necrosis,
Complication, Chemoembolization.
INTRODUCTION
Hepatic artery chemoembolization (HACE) has been uti-
lized as part of the treatment of various hepatic tumors. Its
use for neuroendocrine tumors metastatic to the liver has
resulted in both survival benefit and symptomatic im-
provement.1 The potential hepatic complications after
HACE include liver failure, hepatic abscess or necrosis,
portal vein thrombosis, and tumor rupture.
The development of hepatic necrosis after HACE is one of
the most severe hepatic complications that has been de-
scribed. This complication is rare, with fewer than 10
cases reported to date based on a Medline search. Many
additional reports exist of hepatic abscess after HACE,1–10
but abscess and necrosis have important distinctions. In
contrast to hepatic abscess, hepatic necrosis implies that a
significant degree of devitalization of previously normal
liver parenchyma occurs, often in a segmental or lobar
pattern. Most cases of hepatic necrosis are complicated by
infection, particularly involving gram-negative bacteria.
The mortality rate of infected hepatic necrosis is approx-
imately 50%.2
Treatment options for infected hepatic necrosis include
intravenous antibiotics, percutaneous drainage, and open
surgical drainage or liver resection.2 We report the first
case of hepatic necrosis after HACE managed definitively
with laparoscopic hepatic necrosectomy. This report adds
to the growing body of literature supporting the role of
minimally invasive surgery in managing a broad array of
hepatic conditions.
CASE REPORT
A 58-year-old man presented to an outside facility with
abdominal pain and jaundice. The initial workup demon-
strated a large mass involving the head and neck of the
pancreas and multiple bilobar hepatic masses. Liver bi-
opsy was consistent with metastatic pancreatic neuroen-
docrine tumor. An octreotide scan showed evidence of
uptake in both the pancreas and liver. The patient was felt
to have unresectable pancreatic disease and underwent
percutaneous placement of right and left hepatic duct
metal endoprostheses to relieve the biliary obstruction.
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CASE REPORTOn presentation to our facility, the patient reported severe
right upper quadrant pain and debilitating diarrhea de-
spite pancreatic enzyme replacement. Sandostatin therapy
produced little improvement. Surgical resection was not
pursued due to portal vein encasement and extensive
hepatic tumor burden. HACE was recommended as a
palliative procedure.
HACE was performed according to a standard protocol.
The initial angiogram demonstrated numerous small le-
sions throughout the right and left lobes of the liver and
normal hepatopedal portal venous flow. Right hepatic
artery chemoinfusion was performed with a combination
of doxorubicin, mitomycin, and carboplatin in Ethodiol,
followed by embolization using starch microspheres.
The patient presented 7 days after HACE with severe
abdominal pain and signs of sepsis. CT scan of the abdo-
men demonstrated right hepatic lobe infarction (Figure
1). He also suffered from gram-negative bacteremia. The
patient was initially treated with broad-spectrum antibiot-
ics and percutaneous drainage of the liquefied portion of
the liver. He was discharged home after approximately 3
weeks with two 12-French pigtail drains in the infarcted
area. Over the next several months, he suffered from
intermittent episodes of sepsis that usually responded to
antibiotic adjustment and drain replacement. Biliary pa-
tency was ensured with ERCP to exclude a contribution
from biliary obstruction. Due to recurring sepsis and re-
peated drain malfunction, surgical debridement was un-
dertaken.
Laparoscopy was undertaken in a standard fashion by
using carbon dioxide to maintain pneumoperitoneum.
The liver was completely obscured by adhesions involv-
ing both the colon and omentum. By following the pari-
etal peritoneum towards the diaphragm, a large cavity
containing necrotic hepatic tissue was identified. Most of
the necrotic tissue was easily separable from surrounding
hepatic parenchyma and was removed using an Endobag
(Ethicon, Cincinnati, OH) (Figure 2). Cultures of the de-
brided tissue grew Klebsiella pneumoniae. Large sump
drains were laid in the cavity following necrosectomy.
Blood loss was 100mL and operating time was 75 minutes.
Following hepatic necrosectomy, the patient had com-
plete resolution of fevers. He was discharged home after
5 days, and had no further infectious or wound compli-
cations. There was no sign of bile leak. The sump drains
were removed after approximately 3 weeks, and repeat
imaging demonstrated resolution of the hepatic necrosis
and infarct (Figure 3). He remained alive and free of
infection 12 months after HACE, although he has had
progression of the left hepatic tumor burden.
DISCUSSION
Hepatic metastases of neuroendocrine tumors often lead
to severe morbidity and mortality due both to hepatic
complications and the production of numerous biochem-
ical mediators. HACE and other methods of hepatic cy-
toreduction have been shown to improve quality of life
and survival.1,3 Numerous hepatic complications can ac-
company HACE, including liver abscess, necrosis, biloma,
cholangitis, liver failure, and portal vein thrombosis. Large
Figure 2. Necrotic tissue separated from surrounding hepatic
parenchyma and being removed using an Endobag (Ethicon,
Cincinnati, OH).
Figure 3. Repeat computed tomographic scan of the abdomen,
demonstrating resolution of the hepatic necrosis and infarct.
Figure 1. Computed tomographic scan of the abdomen demon-
strating right hepatic lobe infarction.
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less than 1%.6,7
Hepatic necrosis has rarely been reported after HACE,
which in part may reflect the lack of distinction between
abscess and necrosis. Intuitively, a regional therapy such
as HACE that devitalizes a segmental or lobar distribution
should be considered necrosis, whereas smaller focal ar-
eas might be considered abscesses. Several reports have
consistently shown bilioenteric communication, biliary
stents, or other biliary abnormalities to be the most im-
portant predisposing factor for the development of post-
HACE liver abscess.2,7–10 Our patient had a pre-existing
biliary endoprosthesis, which likely predisposed to infec-
tion. We speculate that an additional ischemic insult to the
right lobe by portal vein encasement by the primary tumor
may have contributed to right lobe necrosis.
Management of hepatic abscess or necrosis after chemo-
embolization consists of antibiotics and in most cases an
attempt at drainage. Small abscesses in stable patients can
be managed with antibiotics alone, but patients with se-
vere sepsis or bacteremia should undergo drainage. In
many cases this can be performed percutaneously and in
refractory cases with laparoscopy or laparotomy. By com-
parison, the management of hepatic necrosis is often more
complex because of both the severity of associated sepsis
and the risk of liver failure due to destruction of unin-
volved parenchyma. Treatment of hepatic necrosis in-
cludes antibiotics along with drainage, debridement, or
resection of necrotic liver.
Our report is the first to describe a minimally invasive
approach to hepatic necrosis. The current case was well
suited for necrosectomy because the 3-month delay since
onset had resulted in a large degree of liquefaction, which
in turn facilitated separation of the devitalized tissue from
normal liver. If early surgical intervention was required
before liquefaction was established, there might have
been a higher risk of bleeding and possibly the need for
lobar or segmental resection.
Laparoscopic liver operations are a relatively new option
available in the treatment of liver conditions. The advan-
tages of laparoscopic techniques are multiple and include
decreased postoperative pain, shorter length of stay and
more rapid return of normal activity. In patients such as
the one described here, with infectious complications
superimposed on hepatic metastases, the morbidity of
laparotomy can be overwhelming due to malnutrition,
ascites, and poor functional reserve. In this setting, the
benefits of the minimally invasive hepatic approach are
compounded.
CONCLUSION
Infected hepatic necrosis is a rare but devastating compli-
cation of hepatic artery chemoembolization. Biliary-en-
teric communication, indwelling biliary stents or prior
biliary manipulation may increase the risk of this compli-
cation. Minimally invasive surgical techniques, as de-
scribed here, add an important management option, and
should be considered in select cases when antibiotics and
percutaneous drainage have failed.
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